Search by Drug Name or NDC
NDC 55264-0107-02 SINSIN MULPAS 4500; 100; 4200; 6900 mg/120mL; mg/120mL; mg/120mL; mg/120mL Details
SINSIN MULPAS 4500; 100; 4200; 6900 mg/120mL; mg/120mL; mg/120mL; mg/120mL
SINSIN MULPAS is a TOPICAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Sinsin Pharmaceutical Co., Ltd.. The primary component is CAMPHOR (SYNTHETIC); CHLORPHENIRAMINE MALEATE; MENTHOL; METHYL SALICYLATE.
Product Information
NDC | 55264-0107 |
---|---|
Product ID | 55264-107_f5b7bc7f-1a07-5a6d-e053-2a95a90a84d6 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | SINSIN MULPAS |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | L-menthol, Methyl salicylate, DL-camphor, Chlorpheniramine maleate, Thymol |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | TOPICAL |
Active Ingredient Strength | 4500; 100; 4200; 6900 |
Active Ingredient Units | mg/120mL; mg/120mL; mg/120mL; mg/120mL |
Substance Name | CAMPHOR (SYNTHETIC); CHLORPHENIRAMINE MALEATE; MENTHOL; METHYL SALICYLATE |
Labeler Name | Sinsin Pharmaceutical Co., Ltd. |
Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH NOT FINAL |
Application Number | part348 |
Listing Certified Through | 2024-12-31 |
Package
NDC 55264-0107-02 (55264010702)
NDC Package Code | 55264-107-02 |
---|---|
Billing NDC | 55264010702 |
Package | 1 CONTAINER in 1 BOX (55264-107-02) / 120 mL in 1 CONTAINER (55264-107-01) |
Marketing Start Date | 2019-02-12 |
NDC Exclude Flag | N |
Pricing Information | N/A |